Dec 18 Trump administration wants to import cheaper prescription drugs from abroad By Ricardo Alonso-Zaldivar, Associated Press Health officials unveiled a proposed regulation that would allow states to import many brand name drugs from Canada, with federal oversight. Continue reading
Dec 11 Watch 6:26 News Wrap: House opens debate on bill to lower prescription drug costs In our news wrap Wednesday, the House opened debate on a Democratic bill to lower prescription drug costs through government negotiations. House Speaker Nancy Pelosi appealed for bipartisan support, but Sen. Mitch McConnell said he won’t bring the bill up… Continue watching
Jul 26 WATCH: Patients affected by rising drug prices testified before House committee By Laura Santhanam The hearing on Capitol Hill comes at a time when the Trump administration has made a push to reduce drug prices and the cost of healthcare overall. Continue reading
Jul 12 The Trump administration’s move to shelve a plan aimed at lowering drug prices, explained By Laura Santhanam This week, the Trump administration reversed its position on reforming the drug rebate system. Analysts and advocates say there may be better approaches to lower out-of-pocket costs. Continue reading
May 16 Why drug prices listed in TV ads might not be what you pay By Arlene Weintraub The U.S. Centers for Medicare & Medicaid Services is requiring drug makers to include “list prices” in television ads for all medicines covered by Medicare or Medicaid that cost $35 or more. Continue reading
Feb 27 Drug company CEOs admit prescription prices are too high. But will they change? By Laura Santhanam Together, the pharmaceutical companies that testified before Congress this week earn billions of dollars treating the world’s maladies and operating under the premise that today’s profits will fund research and development for tomorrow’s cures. But at what price?… Continue reading
Feb 26 Watch 5:56 Lawmakers grill pharmaceutical executives over drug prices, but CEOs avoid big pledges Health care costs are a major concern for Americans, who spend more on prescription drugs than residents of any other country. On Tuesday, executives from seven of the biggest pharmaceutical companies appeared before a Senate committee to explain their rising… Continue watching
Feb 26 Pharma executives say they support ban on some anti-competitive practices By Associated Press Some drugmakers have blocked competition for their medications by preventing would-be competitors from obtaining samples of the drugs. Drug executives who testified before Congress Tuesday said they do not use this tactic. Continue reading
Feb 26 WATCH: Drug companies ‘bear none of the consequences’ of skyrocketing prices, Sen. Wyden says By Ricardo Alonso-Zaldivar, Matthew Perrone, Associated Press The hearing marks the first time lawmakers have called top industry executives to account for rising prices that are squeezing Americans. Continue reading
Feb 01 Watch 9:24 Sec. Azar on how new proposal ‘brings transparency’ to drug pricing A new rule bans pharmaceutical companies from providing rebates to middlemen and insurers in exchange for choosing their drugs. Health and Human Services Secretary Alex Azar also called on Congress to pass a new prescription drug discount plan that would… Continue watching